title: Update on the treatment of peripheral arthritis in psoriatic arthritis.
abstract: Psoriatic arthritis is a chronic, disabling disease for which therapies have been borrowed from rheumatoid arthritis and spondylitis. Traditional disease-modifying antirheumatic drugs (DMARDs) remain the first choice for the treatment of peripheral arthritis despite scarce evidence of their efficacy or ability to halt radiographic progression. Tumor necrosis factor antagonists have the greatest level of evidence for symptom control and radiographic progression. They are currently used after the failure of DMARDs to effectively treat peripheral arthritis, enthesitis, and dactylitis, and are the first choice when axial disease predominates. Despite the use of these treatments, 30% to 40% of patients will still have active disease. Among new drugs, evidence of efficacy has already been published with regard to anti-IL12/23 monoclonal antibody (ustekimumab) and golimumab. Results are forthcoming from trials with certolizumab pegol, abatacept, and rituximab. As knowledge of the pathogenesis of psoriatic arthritis evolves and differences among other arthritis conditions become evident, therapies targeting these distinct features are needed.
authors.affiliation: Sección Reumatología, Servicio de Clínica Medica, Hospital Italiano de Buenos Aires and Fundación PM, Capital Federal, Argentina. enrique.soriano@hospitalitaliano.org.ar
authors.forename: Enrique R
authors.initials: ER
authors.lastname: Soriano
authors.forename: Javier
authors.initials: J
authors.lastname: Rosa
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D001685:Biological Factors / Q000627:therapeutic use*; D006801:Humans; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D000069549:Ustekinumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D001685:Biological Factors; D014409:Tumor Necrosis Factor-alpha; C529000:golimumab; D000069549:Ustekinumab
references.citation: Rheumatology (Oxford). 2003 Jun;42(6):778-83
references.pmid: 12730539
references.citation: Arthritis Rheum. 2004 Jul;50(7):2264-72
references.pmid: 15248226
references.citation: Cochrane Database Syst Rev. 2005 Jul 20;(3):CD005471
references.pmid: 16034981
references.citation: J Am Acad Dermatol. 2009 Mar;60(3):402-11
references.pmid: 19028407
references.citation: Rheumatology (Oxford). 2008 Nov;47(11):1664-70
references.pmid: 18725374
references.citation: Clin Exp Rheumatol. 1995 Sep-Oct;13(5):589-93
references.pmid: 8575136
references.citation: Arthritis Rheum. 2009 Apr;60(4):976-86
references.pmid: 19333944
references.citation: Ann Rheum Dis. 2010 Jan;69(1):206-9
references.pmid: 19204015
references.citation: Ann Rheum Dis. 2007 Oct;66(10):1393-7
references.pmid: 17613555
references.citation: Rheumatology (Oxford). 2006 Aug;45(8):1029-38
references.pmid: 16782734
references.citation: Lancet. 2009 Feb 21;373(9664):633-40
references.pmid: 19217154
references.citation: J Rheumatol. 2008 Mar;35(3):469-71
references.pmid: 18085735
references.citation: Arthritis Rheum. 2008 Jul 15;59(7):996-1001
references.pmid: 18576309
references.citation: Arthritis Rheum. 2005 Oct;52(10):3279-89
references.pmid: 16200601
references.citation: Curr Rheumatol Rep. 2007 Dec;9(6):442-8
references.pmid: 18177596
references.citation: Br J Rheumatol. 1998 Jul;37(7):760-5
references.pmid: 9714353
references.citation: Ann Rheum Dis. 2006 Aug;65(8):1038-43
references.pmid: 16439444
references.citation: J Rheumatol. 2006 Jul;33(7):1422-30
references.pmid: 16724372
references.citation: Arthritis Rheum. 2007 Feb;56(2):476-88
references.pmid: 17265483
references.citation: J Rheumatol. 2007 Nov;34(11):2273-84
references.pmid: 17896800
references.citation: Clin Rheumatol. 2008 Jul;27(7):823-6
references.pmid: 18030515
references.citation: Curr Opin Rheumatol. 2006 Jul;18(4):347-53
references.pmid: 16763453
references.citation: Arthritis Rheum. 2004 Jun;50(6):1939-50
references.pmid: 15188371
references.citation: J Rheumatol. 2006 Apr;33(4):712-21
references.pmid: 16463435
references.citation: Ann Rheum Dis. 2008 Dec;67(12):1787-90
references.pmid: 19005158
references.citation: J Am Acad Dermatol. 2008 May;58(5):851-64
references.pmid: 18423261
references.citation: Joint Bone Spine. 2007 Dec;74(6):638-46
references.pmid: 18065252
references.citation: J Dermatolog Treat. 2009;20(2):100-8
references.pmid: 18923992
references.citation: Ann Rheum Dis. 2005 Mar;64 Suppl 2:ii14-7
references.pmid: 15708927
references.citation: Arthritis Rheum. 2007 Apr;56(4):1051-66
references.pmid: 17393414
references.citation: Rheumatology (Oxford). 2005 Mar;44(3):390-7
references.pmid: 15695305
references.citation: J Cutan Med Surg. 2007 Mar-Apr;11(2):57-66
references.pmid: 17374316
references.citation: Clin Exp Rheumatol. 2007 Nov-Dec;25(6):881-4
references.pmid: 18173924
references.citation: Arthritis Rheum. 2005 Apr;52(4):1227-36
references.pmid: 15818699
references.citation: Ann Rheum Dis. 2008 Jun;67(6):855-9
references.pmid: 17827183
references.citation: Rheumatology (Oxford). 2007 Nov;46(11):1729-35
references.pmid: 17956918
references.citation: Arthritis Rheum. 2009 Feb 15;61(2):233-9
references.pmid: 19177544
references.citation: Br J Rheumatol. 1997 Jan;36(1):95-9
references.pmid: 9117186
references.citation: Ann Rheum Dis. 2003 Jan;62(1):68-70
references.pmid: 12480674
references.citation: Arthritis Rheum. 2007 Feb 15;57(1):154-60
references.pmid: 17266089
references.citation: J Rheumatol. 2001 Oct;28(10):2274-82
references.pmid: 11669169
references.citation: Clin Exp Rheumatol. 2006 Jan-Feb;24(1):70-8
references.pmid: 16539822
references.citation: J Rheumatol. 2008 May;35(5):869-76
references.pmid: 18381786
references.citation: Arthritis Rheum. 2006 May;54(5):1638-45
references.pmid: 16646026
references.citation: J Clin Invest. 1999 May;103(9):1243-52
references.pmid: 10225967
references.citation: Ann Rheum Dis. 2009 May;68(5):702-9
references.pmid: 18684743
references.citation: J Rheumatol. 2008 Jul;35(7):1354-8
references.pmid: 18464305
references.citation: J Rheumatol. 2005 Nov;32(11):2183-5
references.pmid: 16265699
references.citation: J Rheumatol. 2006 Jul;33(7):1228-30
references.pmid: 16821263
references.citation: J Rheumatol. 1995 Feb;22(2):241-5
references.pmid: 7738945